Sindhu Ramchandren MD

Assistant Professor, Neurology
Specialties: 
Pediatric Neurology, Neurology
Clinical Interests:

Neuromuscular disorders of any type in adults and children; Inherited neuropathy (CMT, HNPP); inflammatory neuropathy (GBS, CIDP, MMN, antibody-mediated neuropathies); myopathy, muscular dystrophy.

 

U of M CMT and MDA Clinic

Phone: 734-647-3863

Fax: 734-232-9955 

Locations

U of M CMT and MDA Clinic

C.S. Mott Children's Hospital
1500 E. Medical Center Drive, 6th Floor
Ann Arbor
MI
48109
Phone:
734-647-3863
Fax:
734-232-9955

U of M Neurology

Taubman Center Floor 1, Reception C
1500 E Medical Center Dr SPC 5322
Ann Arbor
MI
48109
Phone:
734-936-9010
Fax:
734-615-4991

Credentials

Medical School or Training

  • University of Texas Health Science Center, 2000

Residency

  • University of Pennsylvania School of Medicine, Neurology, PA, 2004

Fellowship

  • Neuromuscular Disease, Johns Hopkins School of Medicine, 2005

Board Certification

  • Electrodiagnostic Medicine

  • Neurology

Research

Charcot Marie Tooth (CMT) in children and adults, measures of quality of life and functional disability in children and adults with inherited neuropathy, early phase clinical trials in neuromuscular disorders, cost-effective analysis in neuromuscular disorders.

Information on Dr. Ramchandren’s clinical and research interests  

Biography

Sindhu Ramchandren, MD, MS, is a Director of the Pediatric and Adult CMT and MDA clinic at the University of Michigan. Dr. Ramchandren completed her medical degree at the University of Texas-Houston, and a Master’s degree in Clinical Research Design and Statistical Analysis at the University of Michigan School of Public Health. She completed a residency in neurology at the University of Pennsylvania and a fellowship in Clinical Neurophysiology- EMG at Johns Hopkins University. Dr. Ramchandren’s clinical and research interests focus on both adults and children. She is the principal investigator of an NIH-funded project to develop and validate a quality of life instrument in children with CMT. Her current research includes the identification and validation of functionally-relevant, patient-centered outcome measures in neuromuscular disorders; identifying clinical and laboratory biomarkers of axonal dysfunction, and identifying new treatments for neuromuscular disorders, through well-designed clinical trials utilizing functionally relevant outcome measures.